Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab

Abroad (travel likely)Recruiting

Conditions

Diabetic Retinopathy (DR) · Diabetic Macular Edema (DME)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Hospital Osijek, Osijek, Croatia
Contact: Study coordinator (Ivanka Maduna) · ivankamadun@gmail.com · 0981962588

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales

Diabetic Retinopathy (DR) · Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus · Diabetic Macular Edema (DME)

Abroad (travel likely)Recruiting

Llanelli, United Kingdom

To Evaluate the Efficacy and Safety of N-acetyl Cysteine Administration in Patients With Diabetic Retinopathy

Diabetic Retinopathy (DR)

Abroad (travel likely)RecruitingPHASE4

Cairo, Egypt · Cairo, Egypt

Proteomic Biomarker Identification in Age-Related Macular Degeneration, Diabetic Retinopathy and Retinal Detachment

Age-Related Macular Degeneration (AMD) · Diabetic Retinopathy (DR) · Retinal Detachment

Abroad (travel likely)Recruiting

Roma, Italy

Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus

Diabetic Retinopathy (DR) · Diabete Mellitus · Fundus Photography

Abroad (travel likely)Recruiting

Incheon, South Korea